Patents Assigned to Prutech Research And Development
  • Patent number: 5223424
    Abstract: The present invention provides a recombinant fusion protein comprising an antigenic amino acid sequence fused to at least a portion of the gpX glycoprotein from pseudorabies virus. Such a protein may be formulated into a vaccine and delivered to an animal using a live herpesvirus vector adapted to express the fusion protein.
    Type: Grant
    Filed: July 27, 1988
    Date of Patent: June 29, 1993
    Assignee: Prutech Research And Development
    Inventors: Mark D. Cochran, Christina H. Chiang, Richard D. MacDonald